ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) (ERIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01705509
Recruitment Status : Terminated (Study terminated due to lack of resources.)
First Posted : October 12, 2012
Last Update Posted : April 6, 2017
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Cardiovascular Institute of the South Clinical Research Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 31, 2017
  Actual Study Completion Date : March 31, 2017
Publications:
Lloyd-Jones et al Executive summary: heart disease and stroke statistics-- 2010 update: a report from the American Heart Association.
Itoh, H et al. Oxygen uptake abnormalities during exercise in coronary artery disease. In Cardiopulmonary Exercise Testing and Cardiovascular Health. Edited by K. Wasserman, Published by Futura Publishing Company, Armonk NY, 2002.